The Role of the IL-20 Subfamily in Glaucoma

Figure 4

MMP activity in conditioned media from normal (white bars, ) and patient fibroblasts with the IL-20RB T104M mutation (dark bars, ) treated with cytokines (reprinted with copyright permission from Journal of Ocular Pharmacology and Therapeutics). IL-20 was added at 100 or 200 ng/mL and IL-19 and IL-24 were used at 100 ng/mL.